Javascript must be enabled to continue!
Patient‐centred care in haemophilia: Patient perspectives on visualization and participation in decision‐making
View through CrossRef
AbstractIntroduction and AimThe British Columbia Adult Haemophilia Team recently adopted a patient‐centred care approach. The team presented visual information on an individual's pharmacokinetic profile and bleed history and encouraged patients to participate in treatment decisions. This qualitative study explored how this approach changed patients’ understanding of haemophilia and how it facilitated them to make treatment decisions.MethodsWe interviewed 18 males with mild, moderate or severe haemophilia, using a convenience sample from the adult haemophilia clinic at St. Paul's hospital in Vancouver, Canada. Interviews were recorded and transcribed verbatim and analyzed using descriptive content analysis.ResultsMost participants reported that reviewing visual information with the Clinic Team helped them in their communication with their care providers during their annual review clinic appointment. Despite this improved communication, for some the most important feature of their treatment was that they had switched from on‐demand treatment to prophylactic treatment in recent years and were able to prevent bleeds. Almost half of the participants reported that the visual information presented increased their understanding of haemophilia and the pharmacokinetics of coagulation factor. Three patients improved their treatment adherence or had changed their prophylaxis schedules based on this. Most participants felt that they were involved in decision‐making about their treatment schedule, which they appreciated. On the other hand, two participants thought the Clinic Team should make these decisions.ConclusionParticipants perceived the patient‐centred prophylaxis approach helpful because it enhanced communication with the Clinic Team, increased their understanding of haemophilia and pharmacokinetics of coagulation factor and facilitated treatment decisions.
Title: Patient‐centred care in haemophilia: Patient perspectives on visualization and participation in decision‐making
Description:
AbstractIntroduction and AimThe British Columbia Adult Haemophilia Team recently adopted a patient‐centred care approach.
The team presented visual information on an individual's pharmacokinetic profile and bleed history and encouraged patients to participate in treatment decisions.
This qualitative study explored how this approach changed patients’ understanding of haemophilia and how it facilitated them to make treatment decisions.
MethodsWe interviewed 18 males with mild, moderate or severe haemophilia, using a convenience sample from the adult haemophilia clinic at St.
Paul's hospital in Vancouver, Canada.
Interviews were recorded and transcribed verbatim and analyzed using descriptive content analysis.
ResultsMost participants reported that reviewing visual information with the Clinic Team helped them in their communication with their care providers during their annual review clinic appointment.
Despite this improved communication, for some the most important feature of their treatment was that they had switched from on‐demand treatment to prophylactic treatment in recent years and were able to prevent bleeds.
Almost half of the participants reported that the visual information presented increased their understanding of haemophilia and the pharmacokinetics of coagulation factor.
Three patients improved their treatment adherence or had changed their prophylaxis schedules based on this.
Most participants felt that they were involved in decision‐making about their treatment schedule, which they appreciated.
On the other hand, two participants thought the Clinic Team should make these decisions.
ConclusionParticipants perceived the patient‐centred prophylaxis approach helpful because it enhanced communication with the Clinic Team, increased their understanding of haemophilia and pharmacokinetics of coagulation factor and facilitated treatment decisions.
Related Results
Autonomy on Trial
Autonomy on Trial
Photo by CHUTTERSNAP on Unsplash
Abstract
This paper critically examines how US bioethics and health law conceptualize patient autonomy, contrasting the rights-based, individualist...
Treatment trends for haemophilia A and haemophilia B in the United States: results from the 2010 practice patterns survey
Treatment trends for haemophilia A and haemophilia B in the United States: results from the 2010 practice patterns survey
Summary. Frequent evaluation of haemophilia treatment is necessary to improve patient care. The 2010 Practice Patterns Survey (PPS) investigated current trends in haemophilia trea...
A preliminary application of a haemophilia value framework to emerging therapies in haemophilia
A preliminary application of a haemophilia value framework to emerging therapies in haemophilia
AbstractIntroductionEmergence of new therapies are anticipated to improve clinical outcomes and quality of life of persons with haemophilia. Challenges in conducting randomized cli...
A transgender person with haemophilia
A transgender person with haemophilia
Abstract
Introduction
Transgender people face many obstacles to accessing healthcare but cultural changes are likely to i...
Patient-Centred Management of Well-Controlled Haemophilia: Obtaining Opinions and Definitions Through a Delphi Consensus
Patient-Centred Management of Well-Controlled Haemophilia: Obtaining Opinions and Definitions Through a Delphi Consensus
Background/Objectives: For people with haemophilia, health-related quality of life mainly depends on the arthropathy caused by repeated joint bleeding. Prophylaxis is the standard ...
Effect of low‐dose factor VIII prophylaxis therapy on bone mineral density and 25(OH) vitamin D level in children with severe haemophilia A
Effect of low‐dose factor VIII prophylaxis therapy on bone mineral density and 25(OH) vitamin D level in children with severe haemophilia A
AbstractBackgroundDecreased bone mineral density (BMD) is a significant morbidity in haemophilia. Vitamin D is important for the bone health of people with haemophilia. Regular fac...
Haemophilia care in Iraq; a multi-centre study
Haemophilia care in Iraq; a multi-centre study
Objectives: To evaluate the level of care available to haemophilia patients.
Method: The descriptive, retrospective analytical study was conducted from December 15, 2020, to March...
Normalisation of Haemostasis in Haemophilia A
Normalisation of Haemostasis in Haemophilia A
Haemophilia A (Factor VIII [FVIII] levels ≤40 IU/dL) is a chronic condition with consequences beyond bleeding complications. Many people with haemophilia A (PwHA) experience pain, ...

